- Global Pharma News & Resources

Global Nosocomial Infections Report 2019 - API Manufacturers, Marketed and Phase III Drugs Landscape, 2019-2021 -

The "Nosocomial Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" drug pipelines has been added to's offering.

Nosocomial Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019 report provides comprehensive insights about marketed and Phase III products for Nosocomial Infections. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country.

Global API Manufacturers of Marketed Products for Nosocomial Infections

Coverage of API manufacturers for Nosocomial Infections marketed products spanning across United States, Europe, China and India. The manufacturers' details include manufacturers' name along with their location.

Emerging Phase III products for Nosocomial Infections

This report provides a comprehensive understanding of the emerging Phase III therapies for Nosocomial Infections which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2021.


  • A review of the marketed products for Nosocomial Infections including their description, route of synthesis, regulatory milestones, forecasted sales estimates till 2021 and API manufacturer details.
  • Patent information coverage of the marketed products including the patent number, holder, grant and patent expiry details
  • API manufacturers for the marketed products with location details
  • Emerging Phase III product profiles for Nosocomial Infections including product description, developmental activities, licensors & collaborators and chemical information

Key Topics Covered:

1. Report Introduction

2. Nosocomial Infections: Overview

  • Risk Factors
  • Causes
  • Symptoms
  • Pathophysiology
  • Prognosis
  • Diagnosis
  • Treatment

3. Comparative Analysis of Marketed and Emerging Products

4. Marketed Therapies

  • Product Description
  • Route of Synthesis
  • Mechanism of Action
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Adverse Reactions
  • Clinical Trials
  • Regulatory Milestones
  • Product Development Activities
  • United States
  • Europe
  • Historical Global Sales
  • Forecasted Global Sales
  • Patent Details

5. Emerging Therapies (Phase III)

  • Product Description
  • Research and Development
  • Product Development Activities
  • Forecasted Global Sales

For more information about this drug pipelines report visit

View source version on

Editor Details

Last Updated: 28-Jan-2019